2015
DOI: 10.1158/1940-6207.capr-15-0125
|View full text |Cite
|
Sign up to set email alerts
|

Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density

Abstract: Soy supplementation by breast cancer patients remains controversial. No controlled intervention studies have investigated the effects of soy supplementation on mammographic density in breast cancer patients. We conducted a double-blind, randomized, placebo-controlled intervention study in previously treated breast cancer patients (n=66) and high-risk women (n=29). We obtained digital mammograms and breast magnetic resonance imaging (MRI) scans at baseline and after 12 months of daily soy (50 mg isoflavones per… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
30
1
1

Year Published

2016
2016
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(35 citation statements)
references
References 52 publications
1
30
1
1
Order By: Relevance
“…The “early intake” hypothesis, which was first proposed in 1995 [222,223], is consistent with clinical studies showing that in adults, neither soy protein nor isoflavone supplements affect markers of breast cancer risk including mammographic density [229,230] and breast cell proliferation [231,232,233,234,235,236]. It is also consistent with the recognition of the growing evidence linking childhood and adolescent lifestyle and environmental exposures with subsequent risk of cancers arising in adulthood [237].…”
Section: Breast Cancersupporting
confidence: 58%
See 1 more Smart Citation
“…The “early intake” hypothesis, which was first proposed in 1995 [222,223], is consistent with clinical studies showing that in adults, neither soy protein nor isoflavone supplements affect markers of breast cancer risk including mammographic density [229,230] and breast cell proliferation [231,232,233,234,235,236]. It is also consistent with the recognition of the growing evidence linking childhood and adolescent lifestyle and environmental exposures with subsequent risk of cancers arising in adulthood [237].…”
Section: Breast Cancersupporting
confidence: 58%
“…More importantly, the clinical data show that soy isoflavones, regardless of the source, and even when exposure greatly exceeds Japanese intake, do not exert harmful effects on breast tissue [229,230,231,232,233,234,235,236]. These findings are consistent with the conclusion of the EFSA although their review focused on healthy postmenopausal women not breast cancer patients [108].…”
Section: Breast Cancermentioning
confidence: 54%
“…De récentes études ont montré que ni les protéines de soja, ni les aliments au soja, ni les compléments alimentaires d'isoflavones n'ont d'effet sur des marqueurs du risque de cancer du sein comme la densité mammographique (Hooper, 2010 ;Wu, 2015) ou la prolifération des cellules mammaires (Khan et al, 2012 ;Palomares, 2004 ;Sartippour, 2004 ;Shike, 2014).…”
Section: En Cas D'antécédents De Cancer Du Seinunclassified
“…However, mean soy protein intake, which comes from traditional Asian soyfoods in the vast majority of these epidemiologic studies, is below the amounts associated with increases in IGF-1 in the clinical studies so the insight this research provides is limited. In addition, most of the clinical studies that evaluated markers of breast or prostate cancer risk intervened with isoflavone supplements, so this research provides limited insight regarding the effects of soy protein on IGF-1 levels, but it is worth emphasizing that almost without exception, these studies show that soy does not adversely affect breast [78][79][80] or prostate [81,82] tissue. As is the case with bone health, most interest in the cancer and soy relationship is because of isoflavones.…”
Section: Discussionmentioning
confidence: 99%